Results

Total Results: 334 records

Showing results for "phase".

21. Archived: Final Evidence Review: Ovarian Cancer: Screening, May 2004 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review79/ovarian-cancer-screening-2004
    May 15, 2004 - 2002 10  limit 9 to (human and English language) 11  limit 10 to (clinical trial or clinical trial, phase … i or clinical trial, phase ii or clinical trial, phase iii or clinical trial, phase iv or controlled

22. JAMA JATS (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/Nvjr8BPsZhy4XGc7-rGjAH
    June 18, 2018 - The NTCC Phase II and HPV FOCAL trials enrolled women aged 25 to 60 or 65 years and had 2 rounds of … The NTCC Phase II trial found that hrHPV testing alone had a cu- mulative CIN 3+ detection rate twice … The NTCC Phase I, ARTISTIC, and POBASCAM trials reported 2 rounds of screening at 3- to 5-year intervals … I, Swedescreen, ARTISTIC, and POBASCAM), as well as a single trial of primary hrHPV testing (NTCC Phase … The long preclinical phase from infec- tion to development of precancerous lesions and cervical cancer

23. Liquid-Based Cytology and Human Papillomavirus Testing to Screen for Cervical Cancer: A Systematic Review for the U.S. Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/_9KLmyQyMnoE3agQJsgNE-
    November 01, 2011 - For primary HPV screening compared with cy- tology, we found 1 RCT (NTCC phase 2; 49 196 partic- ipants … In phase 2 of the NTCC, a fair-quality Italian RCT comparing Hybrid Capture 2 HPV screening with cytol … The Appendix Table details other interpretation and quality issues with NTCC phase 2. … Four large, fair-quality RCTs (46–49)—NTCC phase 1, POBASCAM, Swedescreen, and ARTISTIC (compris- ing … 2 (39) Finnish Trial (45, 51)‡‡ NTCC Phase 1 (46) POBASCAM (47) Swedescreen (49, 50) ARTISTIC (48

24. Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions: A Systematic Review to Update the USPSTF Recommendations (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/G7CCbu64mf-nCynBkHbFLA
    July 01, 2012 - disease and os- teoporotic fractures, we selected results reported at the end of the trial intervention phase … For conditions that were initiated during exposure but continued after the interven- tion phase, such … as cancer, we used results reported at the end of the trial’s postintervention phase, if available. … The study closed during the recruitment phase, follow-up was short, the power of the study was greatly … mortality; fractures; thrombo- embolic events; coronary heart disease events; and stroke Extension phase

25. Draft Recommendation: Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/menopausal-hormone-therapy-postmenopausal-persons-primary-prevention-chronic-conditions
    April 19, 2022 - although the risk of breast cancer was not significantly lower during the study’s 7.2-year intervention phase … At 20.7 years of followup, persons who received estrogen alone during the intervention phase had a lower … risk of total fractures in persons taking estrogen alone compared with placebo during the intervention phase

26. Archived: Evidence Summary: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/v1-breast-cancer-medications-for-risk-reduction--s
    May 06, 2002 - The first phase used broad search terms and review criteria for all 700 article abstracts; the aim was … A total of 70 articles were examined in phase 2 ( Table A-4 ). … The second phase used more stringent review criteria for full review of the articles themselves to focus … Only four studies met all inclusion criteria from phase 2 ( Table A-4 ). … 630 Included for full article review 70 Phase 2: Full Article Reviews Excluded

27. Archived: Evidence Summary: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction-2002
    May 06, 2002 - The first phase used broad search terms and review criteria for all 700 article abstracts; the aim was … A total of 70 articles were examined in phase 2 ( Table A-4 ). … The second phase used more stringent review criteria for full review of the articles themselves to focus … Only four studies met all inclusion criteria from phase 2 ( Table A-4 ). … 630 Included for full article review 70 Phase 2: Full Article Reviews Excluded

28. Chemo and Couns/2nd instal (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/-hnLT26c2NHs6thK9yznPF
    July 01, 2002 - The first phase used broad search terms and review criteria for all 700 article abstracts; the aim was … A total of 70 articles were examined in phase 2 (Appendix Table 4). … The second phase used more stringent review criteria for full review of the articles themselves to … Only 4 studies met all inclusion criteria from phase 2 (Appendix Table 4). … 630 Included for full article review 70 Phase 2: Full article reviews Excluded after full review 66

29. Evidence Summary: Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/menopausal-hormone-therapy-preventive-medication
    December 12, 2017 - decrease in invasive breast cancer risk compared with placebo during the 7.2-year (median) intervention phase … During the WHI intervention phase,women receiving combination therapy experienced a statistically significant … During the intervention phase of the WHI, women assigned to estrogen plus progestin had a statistically … randomized to estrogen plus progestin developed breast cancer during the 4.1-year (mean) intervention phase … (95%) had any postintervention follow-up and 12,788 (77%) consented to participate in the extension phase

30. Archived: Evidence Summary: Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/menopausal-hormone-therapy-preventive-medication-december-2017
    December 12, 2017 - decrease in invasive breast cancer risk compared with placebo during the 7.2-year (median) intervention phase … During the WHI intervention phase,women receiving combination therapy experienced a statistically significant … During the intervention phase of the WHI, women assigned to estrogen plus progestin had a statistically … randomized to estrogen plus progestin developed breast cancer during the 4.1-year (mean) intervention phase … (95%) had any postintervention follow-up and 12,788 (77%) consented to participate in the extension phase

31. Procedure Manual Appendix VII. Criteria for Assessing External Validity (Generalizability) of Individual Studies | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/procedure-manual/procedure-manual-appendix-vii-criteria-assessing-external-validity-generalizability-individual-studies
    July 01, 2017 - Adherence (i.e., run-in phase, frequent contact to monitor adherence): the study design has features

32. Procedure Manual Appendix VII. Criteria for Assessing External Validity (Generalizability) of Individual Studies | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-appendix-vii-criteria-assessing-external-validity-generalizability-individual-studies
    July 01, 2017 - Adherence (i.e., run-in phase, frequent contact to monitor adherence): the study design has features

33. Draft Recommendation: Prevention of Acquisition of HIV: Preexposure Prophylaxis | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/prevention-human-immunodeficiency-virus-hiv-infection-prep
    December 13, 2022 - long-acting injectable cabotegravir (600 mg intramuscular every 8 weeks, following a 5-week oral lead-in phase … prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase … HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase … Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical … prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase

34. Recommendation: Vision in Children Ages 6 Months to 5 Years: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/vision-in-children-ages-6-months-to-5-years-screening
    September 05, 2017 - from Head Start with amblyopia, amblyopia risk factors, reduced visual acuity, or strabismus. 1 , 33 Phase … identifying amblyopia risk factors or clinically significant nonamblyogenic refractive error. 1 In phase … In phase 2 of the VIP study, positive LRs were 4.9 (95% CI, 4.0 to 6.0) and 3.7 (95% CI, 3.0 to 4.7) … in the moderate range for detecting refractive error or strabismus. 1 Ocular Alignment Tests In phase … CI, 5.6 to 19.4) and the negative LR was 0.0. 1 Direct Comparisons of Different Screening Tests Phase

35. Archived: Hypertension: Screening, 1996 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/hypertension-screening-1996
    January 01, 1996 - Korotkoff sounds or reading the manometer), inattention, inconsistency in recording Korotkoff sounds (e.g., Phase … Phase V), and subconscious bias (e.g., "digit preference" for numbers ending with zero or preconceived … Third, the disappearance of Korotkoff sounds (Phase V) is often difficult to hear in children and Phase … Results of the Trials of Hypertension Prevention, Phase 1.

36. Vision Screening in Children Aged 6Months to 5 Years: Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/wyAJqjxBX_dHMF3WdA7WNt
    September 05, 2017 - from Head Start with amblyopia, amblyopia risk factors, reduced visual acuity, or strabismus.1,33 Phase … Phase 2 of the study compared screening performed by nurses vs lay staff and focused on 4 of the 11 … identifying amblyopia risk factors or clinically significant nonamblyogenic refractive error.1 In phase … in the mod­ erate range for detecting refractive error or strabismus.1 Ocular Alignment Tests In phase … 95% CI, 5.6-19.4) and the negative LR was 0.0.1 Direct Comparisons of Different Screening Tests Phase

37. Evidence Summary: Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults With Cardiovascular Risk Factors: Behavioral Counseling Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/healthy-diet-and-physical-activity-counseling-adults-with-high-risk-of-cvd
    November 24, 2020 - Recruitment for phase II of the Trials of Hypertension Prevention: effective strategies and predictors … Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, phase I. … Weight loss intervention in phase 1 of the Trials of Hypertension Prevention. … Baseline characteristics of participants in phase I of the Trials of Hypertension Prevention. … I Collaborative Research Group; TOHP II CRG, Trials of Hypertension Prevention–Phase II Collaborative

38. Archived: Evidence Summary: Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults: Behavioral Counseling, 2012 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary13/healthful-diet-and-physical-activity-for-cardiovascular-disease-prevention-in-adults-behavioral-counseling
    December 07, 2010 - Results of the Trials of Hypertension Prevention, Phase I. JAMA. 1992;267:1213-20. … Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, phase I. … Phase I design. Ann Epidemiol. 1991;1:455-71. [PMID: 1669525] 96. … The Trials of Hypertension Prevention, phase II. Arch Intern Med. 1997;157: 657-67. … Trials of Hypertension Prevention (phase II).

39. Archived: Final Evidence Summary: Healthy Diet and Physical Activity: Counseling for CVD Prevention in Adults | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary27/healthy-diet-and-physical-activity-counseling-for-cvd-prevention-in-adults
    December 15, 2010 - Results of the Trials of Hypertension Prevention, Phase I. JAMA. 1992;267:1213-20. … Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, phase I. … Phase I design. Ann Epidemiol. 1991;1:455-71. … The Trials of Hypertension Prevention, phase II. Arch Intern Med. 1997;157: 657-67. … Trials of Hypertension Prevention (phase II).

40. Archived: Evidence Summary: Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults: Behavioral Counseling, 2012 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary13/healthful-diet-and-physical-activity-for-cardiovascular-disease-prevention-in-adults-behavioral-counseling-2012
    December 07, 2010 - Results of the Trials of Hypertension Prevention, Phase I. JAMA. 1992;267:1213-20. … Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, phase I. … Phase I design. Ann Epidemiol. 1991;1:455-71. [PMID: 1669525] 96. … The Trials of Hypertension Prevention, phase II. Arch Intern Med. 1997;157: 657-67. … Trials of Hypertension Prevention (phase II).